Pub. Date : 2010 Mar 15
PMID : 20197479
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | These strategies include upfront treatment with next-generation tyrosine kinase inhibitors, such as dasatinib, nilotinib, or bosutinib, which also target BCR-ABL but with increased in vitro potency compared with imatinib, and possibly a reduced potential for resistance. | Dasatinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |